Results of a trial with topotecan dose escalation and concurrent thoracic radiation therapy for locally advanced, inoperable nonsmall cell lung cancer.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 8985046)

Published in Int J Radiat Oncol Biol Phys on December 01, 1996

Authors

M V Graham1, M Jahanzeb, C M Dresler, J D Cooper, B Emami, J E Mortimer

Author Affiliations

1: Radiation Oncology Center, Washington University Medical School, St. Louis, MO 63110, USA.

Articles by these authors

Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med (1992) 7.40

Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) Int J Radiat Oncol Biol Phys (1999) 6.16

Regional lymph node classification for lung cancer staging. Chest (1997) 5.13

Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial. Lancet (2011) 3.70

Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys (1991) 3.64

Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus. Genes Immun (2008) 3.48

Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev (2001) 3.43

Results of single-lung transplantation for bilateral pulmonary fibrosis. The Toronto Lung Transplant Group. N Engl J Med (1990) 2.85

CD226 Gly307Ser association with multiple autoimmune diseases. Genes Immun (2008) 2.76

Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol (1997) 2.73

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J Natl Cancer Inst (1995) 2.64

MR imaging of diffusion of (3)He gas in healthy and diseased lungs. Magn Reson Med (2000) 2.55

Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest (2000) 2.46

Adverse event management in patients with advanced cancer receiving oral everolimus: focus on breast cancer. Ann Oncol (2014) 2.29

The evolution of tracheal injury due to ventilatory assistance through cuffed tubes: a pathologic study. Ann Surg (1969) 2.28

Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials. Int J Radiat Oncol Biol Phys (1993) 2.18

Cost-effective analysis of candidate genes using htSNPs: a staged approach. Genes Immun (2004) 2.07

Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. J Thorac Cardiovasc Surg (1982) 1.99

Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys (1993) 1.95

No association of multiple type 2 diabetes loci with type 1 diabetes. Diabetologia (2009) 1.92

Factors influencing cosmetic results after conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys (1995) 1.88

Long-term clinical outcome after transcervical thymectomy for myasthenia gravis. Ann Thorac Surg (1998) 1.86

A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol (1992) 1.84

Rapid assay for amino acids in serum or urine by pre-column derivatization and reversed-phase liquid chromatography. Clin Chem (1982) 1.79

N2 (clinical) non-small cell carcinoma of the lung: prospective trials of radiation therapy with total doses 60 Gy by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys (1991) 1.77

Experience with primary neoplasms of the trachea and carina. J Thorac Cardiovasc Surg (1984) 1.75

A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104. Int J Radiat Oncol Biol Phys (1997) 1.72

Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys (1997) 1.65

Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys (1991) 1.65

Massive hiatal hernia with incarceration: a report of 53 cases. Ann Thorac Surg (1983) 1.60

The current role of mediastinoscopy in the evaluation of thoracic disease. J Thorac Cardiovasc Surg (1999) 1.59

Primary tracheal anastomosis after resection of the cricoid cartilage with preservation of recurrent laryngeal nerves. J Thorac Cardiovasc Surg (1975) 1.58

Donor lung procurement: assessment and operative technique. Ann Thorac Surg (1993) 1.54

Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected]. Neurobiol Dis (1999) 1.54

Technique of successful lung transplantation in humans. J Thorac Cardiovasc Surg (1987) 1.54

Experimental production and prevention of injury due to cuffed tracheal tubes. Surg Gynecol Obstet (1969) 1.53

Positron emission tomographic assessment of "metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapy. Eur J Nucl Med (1999) 1.49

Ten-year outcomes for pathologic node-positive patients treated in RTOG 75-06. Int J Radiat Oncol Biol Phys (1998) 1.49

Lung volume reduction surgery: comparison of preoperative radiologic features and clinical outcome. Radiology (1997) 1.48

Prospective evaluation of mediastinoscopy for assessment of carcinoma of the lung. J Thorac Cardiovasc Surg (1986) 1.47

Single versus bilateral lung transplantation for idiopathic pulmonary fibrosis: a ten-year institutional experience. J Thorac Cardiovasc Surg (2000) 1.46

Outcome of Medicare patients with emphysema selected for, but denied, a lung volume reduction operation. Ann Thorac Surg (1998) 1.45

Dominoes--pragmatism or piracy? Transpl Int (1991) 1.44

Management of soft tissue sarcomas of the extremities. Surgery (1991) 1.43

Determination of blood ethanol by gas chromatography. Clin Chim Acta (1971) 1.42

HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. Transplantation (1998) 1.41

Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol (1997) 1.40

Preharvest nitroprusside flush improves posttransplantation lung function. J Heart Lung Transplant (1997) 1.40

The impact of surgical margin status and use of an interstitial implant on T1, T2 oral tongue cancers after surgery. Int J Radiat Oncol Biol Phys (1996) 1.40

The donor lung: infectious and pathologic factors affecting outcome in lung transplantation. J Thorac Cardiovasc Surg (1993) 1.39

Evaluation of the Sigma 60 applicator for regional hyperthermia in terms of scattering parameters. Int J Hyperthermia (1992) 1.39

Afferent and efferent connections of the laterodorsal tegmental nucleus in the rat. Brain Res Bull (1990) 1.37

Separate extraction of cardiac and pulmonary grafts from a single organ donor. Ann Thorac Surg (1988) 1.37

Improved technique for bilateral lung transplantation: rationale and initial clinical experience. Ann Thorac Surg (1990) 1.36

Inactivation of bcl-2 results in progressive degeneration of motoneurons, sympathetic and sensory neurons during early postnatal development. Neuron (1996) 1.35

Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays. J Nucl Med (1995) 1.34

Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung. Int J Radiat Oncol Biol Phys (1998) 1.30

A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11. J Clin Oncol (1990) 1.28

Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation. Transplantation (1999) 1.28

Cancer gene discovery using digital differential display. Cancer Res (2000) 1.27

Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome. J Thorac Cardiovasc Surg (1998) 1.26

Extracellular matrix protein gene expression in atherosclerotic hypertensive pulmonary arteries. Am J Pathol (1992) 1.25

Technique of successful clinical double-lung transplantation. Ann Thorac Surg (1988) 1.23

Smoking cessation and lung cancer resection. Chest (1996) 1.21

Repeatability of quantitative CT indexes of emphysema in patients evaluated for lung volume reduction surgery. Radiology (2001) 1.20

Evaluation of a standard breast tangent technique: a dose-volume analysis of tangential irradiation using three-dimensional tools. Int J Radiat Oncol Biol Phys (2000) 1.20

Experimental and clinical double lung transplantation. J Thorac Cardiovasc Surg (1988) 1.20

Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg (1997) 1.18

Allelotype analysis of esophageal adenocarcinomas: evidence for the involvement of sequences on the long arm of chromosome 4. Cancer Res (1996) 1.17

Supradiaphragmatic ligation of the thoracic duct in intractable chylous fistula. Ann Thorac Surg (1981) 1.17

Record performances at the Boston Marathon: biometeorological factors. Int J Biometeorol (1989) 1.17

Retinoic acid-resistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity. Blood (1992) 1.16

Cytomegalovirus infection and pneumonitis. Impact after isolated lung transplantation. Washington University Lung Transplant Group. Am Rev Respir Dis (1993) 1.16

Critical dependence of respiratory rhythmicity on metabolic CO2 load. J Appl Physiol Respir Environ Exerc Physiol (1981) 1.15

Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group. Ann Thorac Surg (1995) 1.15

The role of transbronchial lung biopsy in the treatment of lung transplant recipients. An analysis of 200 consecutive procedures. Chest (1992) 1.14

Results of transcervical thymectomy for myasthenia gravis in 100 consecutive patients. Ann Surg (1999) 1.14

Direct revascularization of bronchial arteries for lung transplantation: an anatomical study. Ann Thorac Surg (1990) 1.12

The Washington University-Barnes Hospital experience with lung transplantation. Washington University Lung Transplantation Group. JAMA (1991) 1.12

Absence of p75NTR causes increased basal forebrain cholinergic neuron size, choline acetyltransferase activity, and target innervation. J Neurosci (1997) 1.12

Chronic expanding hematoma of the thorax. J Thorac Cardiovasc Surg (2001) 1.11

Results of treatment of patients with maxillary sinus carcinoma. Cancer (1998) 1.11

Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trials. Int J Radiat Oncol Biol Phys (1999) 1.11

Use of the silicone tracheal T-tube for the management of complex tracheal injuries. J Thorac Cardiovasc Surg (1981) 1.10

Comparison of early functional results after volume reduction or lung transplantation for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg (1996) 1.10

Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs. J Thorac Cardiovasc Surg (1995) 1.10

Prostaglandin production associated with the pulmonary vascular response to complement activation. Surgery (1980) 1.10

Systemic infection with Alaria americana (Trematoda). Can Med Assoc J (1976) 1.10

Trachea-innominate artery fistula: successful management of 3 consecutive patients. Ann Thorac Surg (1977) 1.08

A low-pressure cuff for tracheostomy tubes to minimize tracheal injury. A comparative clinical trial. J Thorac Cardiovasc Surg (1971) 1.07

Bronchial dehiscence in lung transplantation: CT evaluation. Radiology (1995) 1.07

Ex vivo adenoviral-mediated gene transfer to lung isografts during cold preservation. Ann Thorac Surg (1997) 1.07

Effect of preoperative irradiation on resectability of colorectal carcinomas. Int J Radiat Oncol Biol Phys (1982) 1.06

The evolution of single lung transplantation for emphysema. The Washington University Lung Transplant Group. J Thorac Cardiovasc Surg (1991) 1.06

Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer. Results of Radiation Therapy Oncology Group 90-15. Cancer (1995) 1.05

Indirect recognition of donor HLA class I peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Transplantation (1999) 1.04

Analytical considerations for microdialysis sampling. Adv Drug Deliv Rev (2000) 1.04

Active collagen synthesis by pulmonary arteries in human primary pulmonary hypertension. Am J Pathol (1993) 1.04

Indeterminate mediastinal invasion in bronchogenic carcinoma: CT evaluation. Radiology (1989) 1.04